Esopahgeal cancer, Gastric cancer, Colorectal cancer, Pancreatic cancer, Breast Cancer
Conditions
Interventions
None listed
Sponsors
Gifu University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients who undertake neoadjuvant therapy (Chemo, Radiotherapy) at Gifu Univ. 2.Patients more than 20 3.Patients 0ver 70 is applicable in the patient agree to participate in this study, 4.Pattients (Esophageal, gastric, colorectal, pancreatic, breast cancer) who are going to take neoadjuvant therapy (including conversion cases), 5.Any cases taking clinical trials are applicable if this study doesn't dusturb the protocol. 6.Participants (and/or the family) agree to participate in this study.
Exclusion criteria
Exclusion criteria: 1.No indication for neoadjuvant therapy, 2.No agreement by the patient, 3.Active duplicated cancer (synchronous or another cancer less than 5 y. 4.Severe medical complications, 5.Severe systhemic disease and HIV. 6.Pregnant or lactating 7.Severe mental disorder 8.Urinary tract infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ROC-ACU for IRC (chemotaxix index reduction score) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. ROC-AUC for CR by IRS, 2. ROC-AUC accorfing to the following deficitions) 1)IRR1(Preop-Pretreatment), 2)IRR2 (Postop-Preop), 3)IRR4(Post op-Pretreatment, 3.Image, Tumor marker, 4.Patholog, 5. DFS, OS | — |
Countries
Japan
Contacts
Public ContactManabu Futamura
Gifu University, Graduate School of Medicine Department of Surgcal Oncology
Outcome results
None listed